Lyomac Logo
Case StudiesCase Study

API and Intermediate Material Lyophilizer Solutions

April 27, 2026Location: GlobalYear: 2025Product: LYOPRO API Lyophilizer Series

LYOMAC offers next-generation freeze-drying solutions for modern API and sterile intermediate manufacturing, with drying capacity from 4 to 2,000 Liters, preserving molecular structures and biological activities.

Lyomac Freeze Drying Solutions for Advanced APIs and Sterile Bulk Materials

LYOMAC, a leader in advanced lyophilization technology, offers next-generation freeze-drying solutions meticulously engineered to meet the unparalleled demands of modern API and sterile intermediate manufacturing. Our freeze dryer is designed not just to remove water, but to preserve the intricate molecular structures and biological activities that define these high-value pharmaceutical assets. Drying capacity ranging from 4 ~ 2,000 Liters.

The Evolving Landscape of APIs and Sterile Intermediates

  1. Peptide & Oligonucleotide APIs: GLP-1 receptor agonists (Semaglutide, Tirzepatide precursors), anticoagulant peptides, siRNA, ASOs. Our precise temperature control preserves their delicate secondary and tertiary structures.
  2. mRNA Vaccine Components & Lipid Nanoparticles (LNPs): mRNA vaccine drug substance precursors, enzymes, pre-formed LNP components. Sterile processing capabilities (CIP/SIP, isolator integration) protect against contamination.
  3. Highly Potent APIs (HPAPIs) & Cytotoxic Drugs: Oncology drugs, hormones. Integrated containment features (closed systems, isolator/RABS interfaces) ensure operator safety and product integrity.
  4. Enzymes, Growth Factors & Cell Culture Media Components: Bioprocessing enzymes, growth factors, sterile cell culture media additives. Low-temperature drying preserves enzymatic activity and protein integrity.
  5. Blood Derivatives & Plasma Fractions: Albumin, immunoglobulin, coagulation factors. Robust validated systems ensure stable formulation for global distribution.

LYOMAC's Next-Generation Freeze Drying Features

  • Unrivaled Process Control: Shelf temperature uniformity within ±0.5°C, controlled freezing & annealing algorithms.
  • Superior Sterility & Containment: Integrated CIP/SIP, seamlessly integratable with isolators or RABS, hydraulic vial stoppering.
  • Advanced Process Monitoring: FDA 21 CFR Part 11 compliant SCADA, optional PAT integration with in-line mass spectrometers.
  • Customization & Scalability: Tailored configurations, modular design from laboratory to full commercial scales.
APIintermediatesterilepeptidemRNAHPAPIlyophilizer